Estimate Recalculated Nov 1, 2024 08:59AM EST
Bali Muralidhar does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Reneo Pharmaceuticals, Inc., EXICURE, INC., and SPRUCE BIOSCIENCES, INC..
Bali Muralidhar's CIK is 0001784138
2021 was Bali Muralidhar's most active year for acquiring shares with 3 total transactions. Bali Muralidhar's most active month to acquire stocks was the month of May. 2021 saw Bali Muralidhar paying a total of $0.00 for 74,000 shares, this is the most they've acquired in one year.
No data available
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!